<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0166367</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-27325</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care policy</subject><subj-group><subject>Treatment guidelines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pulmonology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>South America</subject><subj-group><subject>Brazil</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug therapy</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine disorders</subject><subj-group><subject>Diabetes mellitus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Metabolic disorders</subject><subj-group><subject>Diabetes mellitus</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency</article-title>
<alt-title alt-title-type="running-head">CPGs for NCDs in Brazil</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6925-1201</contrib-id>
<name name-style="western">
<surname>Molino</surname>
<given-names>Caroline de Godoi Rezende Costa</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Romano-Lieber</surname>
<given-names>Nicolina Silvana</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ribeiro</surname>
<given-names>Eliane</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>de Melo</surname>
<given-names>Daniela Oliveira</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Public Health Practice, School of Public Health, University of Sao Paulo, São Paulo, Brazil</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>University of São Paulo Hospital, Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Biological Sciences, Institute of Environmental Sciences, Chemical and Pharmaceutical, Federal University of São Paulo, Diadema, São Paulo, Brazil</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Gan</surname>
<given-names>Siew Hua</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Universiti Sains Malaysia, MALAYSIA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple">
<list-item><p><bold>Conceptualization:</bold> NSRL ER DOM.</p></list-item>
<list-item><p><bold>Formal analysis:</bold> CGRCM.</p></list-item>
<list-item><p><bold>Investigation:</bold> CGRCM DOM.</p></list-item>
<list-item><p><bold>Methodology:</bold> NSRL ER DOM.</p></list-item>
<list-item><p><bold>Project administration:</bold> DOM.</p></list-item>
<list-item><p><bold>Resources:</bold> DOM.</p></list-item>
<list-item><p><bold>Supervision:</bold> DOM NSRL ER.</p></list-item>
<list-item><p><bold>Visualization:</bold> CGRCM.</p></list-item>
<list-item><p><bold>Writing – original draft:</bold> CGRCM.</p></list-item>
<list-item><p><bold>Writing – review &amp; editing:</bold> DOM NSRL ER.</p></list-item></list></p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">melo.daniela@unifesp.br</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>11</issue>
<elocation-id>e0166367</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Molino et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0166367"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Annually, non-communicable diseases (NCDs) kill 38 million people worldwide, with low and middle-income countries accounting for three-quarters of these deaths. High-quality clinical practice guidelines (CPGs) are fundamental to improving NCD management. The present study evaluated the methodological rigor and transparency of Brazilian CPGs that recommend pharmacological treatment for the most prevalent NCDs.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>We conducted a systematic search for CPGs of the following NCDs: asthma, atrial fibrillation, benign prostatic hyperplasia, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease and/or stable angina, dementia, depression, diabetes, gastroesophageal reflux disease, hypercholesterolemia, hypertension, osteoarthritis, and osteoporosis. CPGs comprising pharmacological treatment recommendations were included. No language or year restrictions were applied. CPGs were excluded if they were merely for local use and referred to NCDs not listed above. CPG quality was independently assessed by two reviewers using the Appraisal of Guidelines Research and Evaluation instrument, version II (AGREE II).</p>
</sec>
<sec id="sec003">
<title>Main Findings</title>
<p>“Scope and purpose” and “clarity and presentation” domains received the highest scores. Sixteen of 26 CPGs were classified as low quality, and none were classified as high overall quality. No CPG was recommended without modification (77% were not recommended at all). After 2009, 2 domain scores (“rigor of development” and “clarity and presentation”) increased (61% and 73%, respectively). However, “rigor of development” was still rated &lt; 30%.</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>Brazilian healthcare professionals should be concerned with CPG quality for the treatment of selected NCDs. Features that undermined AGREE II scores included the lack of a multidisciplinary team for the development group, no consideration of patients’ preferences, insufficient information regarding literature searches, lack of selection criteria, formulating recommendations, authors’ conflict of interest disclosures, and funding body influence.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003593</institution-id>
<institution>Conselho Nacional de Desenvolvimento Científico e Tecnológico</institution>
</institution-wrap>
</funding-source>
<award-id>164700/2015-3</award-id>
<principal-award-recipient>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6925-1201</contrib-id>
<name name-style="western">
<surname>Molino</surname>
<given-names>Caroline de Godoi Rezende Costa</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>CGRCM is supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), process number 164700/2015-3. The funding source did not influence the content of this study.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Non-communicable diseases (NCDs) are considered major public health problems, strongly affecting the poorest and most vulnerable population groups [<xref ref-type="bibr" rid="pone.0166367.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0166367.ref002">2</xref>]. NCDs kill 38 million people worldwide each year, and 28 million of these deaths occur in low and middle-income countries. Due to NCD healthcare burdens, the World Health Organization (WHO) has emphasized a need for improving NCD treatment [<xref ref-type="bibr" rid="pone.0166367.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0166367.ref003">3</xref>].</p>
<p>High-quality clinical practice guidelines (CPGs) are fundamental for improving healthcare management, as they are special tools that translate scientific research findings, provide explicit recommendations, and support evidence-based decision making [<xref ref-type="bibr" rid="pone.0166367.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0166367.ref005">5</xref>]. CPG implementation is essential for improving NCD control and patient quality of life, as well as optimizing drug utilization and healthcare resources [<xref ref-type="bibr" rid="pone.0166367.ref006">6</xref>–<xref ref-type="bibr" rid="pone.0166367.ref008">8</xref>]. However, several studies have identified CPGs that suffer from low to moderate quality, which call into question the reliability of such measures among healthcare professionals and managers [<xref ref-type="bibr" rid="pone.0166367.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0166367.ref018">18</xref>].</p>
<p>Several tools have been developed worldwide for evaluating CPG quality [<xref ref-type="bibr" rid="pone.0166367.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0166367.ref020">20</xref>]. For instance, the Appraisal of Guidelines Research and Evaluation instrument [<xref ref-type="bibr" rid="pone.0166367.ref021">21</xref>] version II (AGREE II), published in 2009, has been extensively used, validated in several languages, and covers essential information for comprehensive CPG evaluation [<xref ref-type="bibr" rid="pone.0166367.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0166367.ref020">20</xref>]. Several studies worldwide have been conducted for assessing CPG quality using the AGREE II [<xref ref-type="bibr" rid="pone.0166367.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0166367.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0166367.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0166367.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0166367.ref022">22</xref>–<xref ref-type="bibr" rid="pone.0166367.ref025">25</xref>]; however, very little is known regarding CPG quality among low income countries [<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>]. To date, only one study has evaluated CPG quality in Brazil [<xref ref-type="bibr" rid="pone.0166367.ref018">18</xref>], and none have critically assessed CPGs for NCD treatment quality within a Brazilian sample. Thus, the present study evaluated the methodological rigor and transparency of Brazilian CPGs that recommend pharmacological treatment for the most prevalent NCDs.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Search</title>
<p>The following chronic conditions were selected: asthma, atrial fibrillation, benign prostatic hyperplasia, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease and/or stable angina, dementia, depression, diabetes, gastroesophageal reflux disease, hypercholesterolemia, hypertension, osteoarthritis, and osteoporosis. These conditions were selected given their high observed prevalence within primary care settings [<xref ref-type="bibr" rid="pone.0166367.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0166367.ref034">34</xref>]. We also included CPGs for rheumatic arthritis and Alzheimer´s disease given their high relevance for elderly adults.</p>
<p>We conducted a comprehensive literature search on October 30, 2015: MEDLINE (by PubMed) [<xref ref-type="bibr" rid="pone.0166367.ref035">35</xref>], LILACS (by Virtual Health Library website) [<xref ref-type="bibr" rid="pone.0166367.ref036">36</xref>], and Cochrane Library [<xref ref-type="bibr" rid="pone.0166367.ref037">37</xref>]. On September 9, 2015, we searched the National Guideline Clearinghouse [<xref ref-type="bibr" rid="pone.0166367.ref038">38</xref>] database. <xref ref-type="supplementary-material" rid="pone.0166367.s003">S1 Table</xref> contains the full search strategies used for all databases.</p>
<p>We also searched Google for the following (on September 9, 2015): “clinical guidelines” or “therapeutic guidelines” or “clinical protocol” or “clinical practice guidelines” and “Brazil” for each NCD. Finally, we searched for CPGs on the Brazilian Ministry of Health website (on October 31, 2015) available at: <ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o-ministerio/840-sctie-raiz/daf-raiz/cgceaf-raiz/cgceaf/l3-cgceaf/11646-pcdt" xlink:type="simple">http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o-ministerio/840-sctie-raiz/daf-raiz/cgceaf-raiz/cgceaf/l3-cgceaf/11646-pcdt</ext-link>.</p>
</sec>
<sec id="sec008">
<title>Guideline selection</title>
<p>A CPG was defined according to the Institute of Medicine: “<italic>clinical practice guidelines are statements that include recommendations intended to optimize patient care that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options</italic>” ([<xref ref-type="bibr" rid="pone.0166367.ref039">39</xref>], p4). Inclusion criteria were CPGs that comprised pharmacological treatment recommendations. No language or year restrictions were applied. Exclusion criteria included CPGs without pharmacological treatment recommendations, were only for local use, and/or referred to chronic conditions not already mentioned.</p>
<p>Two independent reviewers first assessed paper titles and abstracts for potential eligibility. Second, reviewers independently screened each full-text article for inclusion criteria. Finally, we checked medical society and Brazilian Ministry of Health websites for any supplemental material. Discrepancies at any stage were resolved through discussion between the two reviewers. When necessary, a third reviewer was included.</p>
</sec>
<sec id="sec009">
<title>Data extraction and quality appraisal</title>
<p>One reviewer performed the data extraction. Next, a second reviewer checked the extraction. Included CPGs were assessed according to specific NCDs, publication year, publisher, guideline type (formulated or adapted), guideline references, funding, and quality appraisal.</p>
<p>CPG quality was assigned using the AGREE II instrument [<xref ref-type="bibr" rid="pone.0166367.ref021">21</xref>]. This instrument was chosen because it is a validated tool in Brazil [<xref ref-type="bibr" rid="pone.0166367.ref040">40</xref>] and is widely used [<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0166367.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0166367.ref041">41</xref>]. The AGREE II comprises 23 items, which are grouped into 6 domains, as well as 2 overall assessment items that allow reviewers to rate overall CPG quality and recommend its use [<xref ref-type="bibr" rid="pone.0166367.ref042">42</xref>]. Items are rated on a 7-point scale: 1 (strongly disagree; there is no relevant information or the concept is poorly described) to 7 (strongly agree; quality of information is excellent and all criteria listed in the AGREE II User’s Manual are met) [<xref ref-type="bibr" rid="pone.0166367.ref021">21</xref>]. Reviewers judged the overall CPG quality taking into account all 23 items in accordance with the AGREE II User’s Manual [<xref ref-type="bibr" rid="pone.0166367.ref021">21</xref>].</p>
<p>Two independent reviewers (CGRCM and DOM) assessed CPG quality. The reviewers were trained on the AGREE II instrument as described in <xref ref-type="supplementary-material" rid="pone.0166367.s001">S1 Appendix</xref>. The reviewers had not previously authored any CPGs. Discrepancies in ratings were verified by calculating Kappa coefficients using VassarStats [<xref ref-type="bibr" rid="pone.0166367.ref043">43</xref>] for each CPG. Kappa coefficients were considered discrepant when ≤0.4, based on Landis and Koch’s criteria [<xref ref-type="bibr" rid="pone.0166367.ref044">44</xref>]. For discrepant CPGs, we identified domains that revealed high discrepancy using a concordance calculator developed by McMaster University [<xref ref-type="bibr" rid="pone.0166367.ref045">45</xref>]. The reviewers then discussed and independently reviewed high discrepant domains. Finally, domain scores were calculated according to the AGREE II User’s Manual.</p>
</sec>
<sec id="sec010">
<title>Analyses</title>
<p>According to the AGREE II User’s Manual, domain scores must not be calculated as a single quality score. The scores of each domain are determined by the total item score percentage with reference to the range between maximum and minimum scores of that particular domain [<xref ref-type="bibr" rid="pone.0166367.ref042">42</xref>].</p>
<p>Despite having no validated method for an overall classification [<xref ref-type="bibr" rid="pone.0166367.ref042">42</xref>], we decided to adopt a metric for overall CPG quality, as shown in <xref ref-type="supplementary-material" rid="pone.0166367.s002">S1 Fig</xref>. We prioritized domain 3 for classifying the overall quality since this domain evaluates methodological rigor during CPG development. Other studies have used different classification metrics for determining overall quality [<xref ref-type="bibr" rid="pone.0166367.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0166367.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0166367.ref047">47</xref>]. Then, to differentiate CPGs’ quality regarding other domain scores, we divided it into high, moderate, and low categories with A to C grading. Thus, overall quality was divided into 9 types according to domain 3 and 2 other domains scores (<xref ref-type="supplementary-material" rid="pone.0166367.s002">S1 Fig</xref>).</p>
<p>Mann-Whitney test was used to test significant difference in domain scores between CPG published before and in/after 2009 (AGREE II publication year). P-values less than 0.05 were considered statistically significant.</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<p>The search strategy retrieved 661 records, of which 58 were considered for full-text screening; 26 met our eligibility criteria and were assessed using the AGREE II (<xref ref-type="fig" rid="pone.0166367.g001">Fig 1</xref>). See <xref ref-type="supplementary-material" rid="pone.0166367.s004">S2 Table</xref> for excluded CPG details.</p>
<fig id="pone.0166367.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0166367.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flowchart of clinical practice guidelines selection.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.g001" xlink:type="simple"/>
</fig>
<p>Most of the included CPGs were published in/after 2009 (85%). None conducted a systematic review of the literature, explicitly declared funding sources, or claimed to be an adapted CPG. <xref ref-type="table" rid="pone.0166367.t001">Table 1</xref> shows general characteristics and AGREE II scores of the included CPGs. Few CPGs were published by the Ministry of Health (6; 23%). Regarding the chronic conditions reviewed, only guidelines for dementia treatment were not found. Diabetes mellitus CPGs were the most common. Only two domains (“scope and purpose” and “clarity and presentation”) obtained scores greater than 60%. Most domains scored less than 30%.</p>
<table-wrap id="pone.0166367.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0166367.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of 26 Brazilian CPGs for the treatment of NCDs and AGREE II scores for each CPG.</title> <p>Domain scores &gt;60% are highlighted in bold and CPGs are sorted according to domain 3 score (from highest to lowest in each disease category).</p></caption>
<alternatives>
<graphic id="pone.0166367.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">Chronic condition</th>
<th align="center" rowspan="2">Publisher</th>
<th align="center" rowspan="2">Year of publication</th>
<th align="center">Domain 1</th>
<th align="center">Domain 2</th>
<th align="center">Domain 3</th>
<th align="center">Domain 4</th>
<th align="center">Domain 5</th>
<th align="center">Domain 6</th>
<th align="center" colspan="2">Overall Guideline Assessment</th>
</tr>
<tr>
<th align="center">Scope and purpose</th>
<th align="center">Stakeholder involvement</th>
<th align="center">Rigor of development</th>
<th align="center">Clarity and presentation</th>
<th align="center">Applicability</th>
<th align="center">Editorial independence</th>
<th align="center">Overall rating</th>
<th align="center">Would reviewers recommend?</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" rowspan="2">Alzheimer´s disease</td>
<td align="center">Ministry of Health[<xref ref-type="bibr" rid="pone.0166367.ref048">48</xref>]</td>
<td align="center">2013</td>
<td align="center"><bold>72%</bold></td>
<td align="center">42%</td>
<td align="center">42%</td>
<td align="center"><bold>67%</bold></td>
<td align="center">31%</td>
<td align="center">42%</td>
<td align="center"><bold>67%</bold></td>
<td align="center">Yes with modification</td>
</tr>
<tr>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref049">49</xref>]</td>
<td align="center">2011</td>
<td align="center"><bold>61%</bold></td>
<td align="center">25%</td>
<td align="center">30%</td>
<td align="center">47%</td>
<td align="center">2%</td>
<td align="center">38%</td>
<td align="center">33%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="2">Asthma</td>
<td align="center">Ministry of Health [<xref ref-type="bibr" rid="pone.0166367.ref050">50</xref>]</td>
<td align="center">2013</td>
<td align="center"><bold>72%</bold></td>
<td align="center">36%</td>
<td align="center">41%</td>
<td align="center"><bold>81%</bold></td>
<td align="center">33%</td>
<td align="center">42%</td>
<td align="center"><bold>67%</bold></td>
<td align="center">Yes with modification</td>
</tr>
<tr>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref051">51</xref>]</td>
<td align="center">2012</td>
<td align="center">42%</td>
<td align="center">47%</td>
<td align="center">20%</td>
<td align="center"><bold>86%</bold></td>
<td align="center">42%</td>
<td align="center">21%</td>
<td align="center">33%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Atrial fibrillation</td>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref052">52</xref>]</td>
<td align="center">2009</td>
<td align="center">3%</td>
<td align="center">8%</td>
<td align="center">19%</td>
<td align="center"><bold>100%</bold></td>
<td align="center">25%</td>
<td align="center">29%</td>
<td align="center">17%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Benign prostatic hyperplasia</td>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref053">53</xref>]</td>
<td align="center">2006</td>
<td align="center">36%</td>
<td align="center">22%</td>
<td align="center">18%</td>
<td align="center">53%</td>
<td align="center">10%</td>
<td align="center">42%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="3">Chronic obstructive pulmonary disease</td>
<td align="center">Ministry of Health [<xref ref-type="bibr" rid="pone.0166367.ref054">54</xref>]</td>
<td align="center">2013</td>
<td align="center"><bold>72%</bold></td>
<td align="center">42%</td>
<td align="center">42%</td>
<td align="center"><bold>81%</bold></td>
<td align="center">33%</td>
<td align="center">42%</td>
<td align="center">58%</td>
<td align="center">Yes with modification</td>
</tr>
<tr>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref055">55</xref>]</td>
<td align="center">2012</td>
<td align="center">56%</td>
<td align="center">8%</td>
<td align="center">26%</td>
<td align="center">58%</td>
<td align="center">10%</td>
<td align="center">33%</td>
<td align="center">33%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref056">56</xref>]</td>
<td align="center">2004</td>
<td align="center">28%</td>
<td align="center">17%</td>
<td align="center">11%</td>
<td align="center">42%</td>
<td align="center">27%</td>
<td align="center">0%</td>
<td align="center">0%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Congestive heart failure</td>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref057">57</xref>]</td>
<td align="center">2012</td>
<td align="center">39%</td>
<td align="center">3%</td>
<td align="center">30%</td>
<td align="center"><bold>67%</bold></td>
<td align="center">13%</td>
<td align="center">46%</td>
<td align="center">33%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Coronary artery disease</td>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref058">58</xref>]</td>
<td align="center">2014</td>
<td align="center"><bold>61%</bold></td>
<td align="center">33%</td>
<td align="center">24%</td>
<td align="center"><bold>86%</bold></td>
<td align="center">31%</td>
<td align="center">21%</td>
<td align="center">17%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Depression</td>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref059">59</xref>]</td>
<td align="center">2011</td>
<td align="center"><bold>64%</bold></td>
<td align="center">22%</td>
<td align="center">24%</td>
<td align="center">47%</td>
<td align="center">2%</td>
<td align="center">38%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="4">Diabetes</td>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref060">60</xref>]</td>
<td align="center">2015</td>
<td align="center">33%</td>
<td align="center">3%</td>
<td align="center">34%</td>
<td align="center"><bold>100%</bold></td>
<td align="center">40%</td>
<td align="center">17%</td>
<td align="center">33%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref061">61</xref>]</td>
<td align="center">2014</td>
<td align="center">58%</td>
<td align="center">8%</td>
<td align="center">23%</td>
<td align="center"><bold>83%</bold></td>
<td align="center">23%</td>
<td align="center">29%</td>
<td align="center">17%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref062">62</xref>]</td>
<td align="center">2011</td>
<td align="center"><bold>75%</bold></td>
<td align="center">39%</td>
<td align="center">22%</td>
<td align="center"><bold>75%</bold></td>
<td align="center">35%</td>
<td align="center">17%</td>
<td align="center">33%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref063">63</xref>]</td>
<td align="center">2004</td>
<td align="center"><bold>78%</bold></td>
<td align="center">14%</td>
<td align="center">21%</td>
<td align="center">39%</td>
<td align="center">2%</td>
<td align="center">17%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Gastroesophageal reflux disease</td>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref064">64</xref>]</td>
<td align="center">2011</td>
<td align="center">33%</td>
<td align="center">17%</td>
<td align="center">21%</td>
<td align="center">44%</td>
<td align="center">0%</td>
<td align="center">38%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="2">Hypercholesterolemia</td>
<td align="center">Ministry of Health [<xref ref-type="bibr" rid="pone.0166367.ref065">65</xref>]</td>
<td align="center">2013</td>
<td align="center"><bold>72%</bold></td>
<td align="center">42%</td>
<td align="center">41%</td>
<td align="center"><bold>75%</bold></td>
<td align="center">31%</td>
<td align="center">42%</td>
<td align="center">58%</td>
<td align="center">Yes with modification</td>
</tr>
<tr>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref066">66</xref>]</td>
<td align="center">2013</td>
<td align="center">50%</td>
<td align="center">6%</td>
<td align="center">16%</td>
<td align="center">36%</td>
<td align="center">17%</td>
<td align="center">4%</td>
<td align="center">8%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="2">Hypertension</td>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref067">67</xref>]</td>
<td align="center">2004</td>
<td align="center">31%</td>
<td align="center">8%</td>
<td align="center">20%</td>
<td align="center">28%</td>
<td align="center">8%</td>
<td align="center">54%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref068">68</xref>]</td>
<td align="center">2010</td>
<td align="center">11%</td>
<td align="center">11%</td>
<td align="center">18%</td>
<td align="center"><bold>86%</bold></td>
<td align="center">35%</td>
<td align="center">46%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center">Osteoarthritis</td>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref069">69</xref>]</td>
<td align="center">2011</td>
<td align="center">39%</td>
<td align="center">22%</td>
<td align="center">27%</td>
<td align="center"><bold>61%</bold></td>
<td align="center">0%</td>
<td align="center">33%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="2">Osteoporosis</td>
<td align="center">Ministry of Health [<xref ref-type="bibr" rid="pone.0166367.ref070">70</xref>]</td>
<td align="center">2014</td>
<td align="center"><bold>72%</bold></td>
<td align="center">42%</td>
<td align="center">43%</td>
<td align="center"><bold>81%</bold></td>
<td align="center">40%</td>
<td align="center">42%</td>
<td align="center"><bold>67%</bold></td>
<td align="center">Yes with modification</td>
</tr>
<tr>
<td align="center">Brazilian Medical Association [<xref ref-type="bibr" rid="pone.0166367.ref071">71</xref>]</td>
<td align="center">2011</td>
<td align="center"><bold>86%</bold></td>
<td align="center">11%</td>
<td align="center">18%</td>
<td align="center">42%</td>
<td align="center">2%</td>
<td align="center">38%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="2">Rheumatoid arthritis</td>
<td align="center">Ministry of Health [<xref ref-type="bibr" rid="pone.0166367.ref072">72</xref>]</td>
<td align="center">2015</td>
<td align="center"><bold>72%</bold></td>
<td align="center">33%</td>
<td align="center">45%</td>
<td align="center"><bold>78%</bold></td>
<td align="center">38%</td>
<td align="center">29%</td>
<td align="center">58%</td>
<td align="center">Yes with modification</td>
</tr>
<tr>
<td align="center">Medical Societies [<xref ref-type="bibr" rid="pone.0166367.ref073">73</xref>]</td>
<td align="center">2012</td>
<td align="center">36%</td>
<td align="center">17%</td>
<td align="center">30%</td>
<td align="center"><bold>75%</bold></td>
<td align="center">42%</td>
<td align="center">21%</td>
<td align="center">25%</td>
<td align="center">No</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p><xref ref-type="fig" rid="pone.0166367.g002">Fig 2</xref> shows that most CPGs were classified as low quality (16; 62%). None were classified as high quality.</p>
<fig id="pone.0166367.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0166367.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Overall quality classification of Brazilian CPGs (n = 26) for the treatment of the most prevalent NCDs.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.g002" xlink:type="simple"/>
</fig>
<p>In terms of whether reviewers would recommend implementing the CPG, we observed that none should be recommended without modifications, and 77% should not be recommended at all. Only CPGs from the Ministry of Health were recommended contingent on modifications.</p>
<p>Improvement in domain scores was observed when comparing CPGs published before and in/after 2009 (<xref ref-type="fig" rid="pone.0166367.g003">Fig 3</xref>). However, only 2 domain scores (“rigor of development” and “clarity and presentation”) demonstrated a significant improvement (p &lt; 0.05).</p>
<fig id="pone.0166367.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0166367.g003</object-id>
<label>Fig 3</label>
<caption>
<title>AGREE II scores obtained, per domain, based on publication year (before and in/after 2009, publication of AGREE II) for Brazilian CPGs.</title>
<p>(*) Statistical significant was observed for “rigor of development” (p = 0.03) and “clarity and presentation (p = 0.01).”</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012" sec-type="conclusions">
<title>Discussion</title>
<p>We performed a systematic search of Brazilian CPGs for treating the most prevalent NCDs within primary care settings. Except for dementia, we identified 26 CPGs, with diabetes mellitus as the most common. Most CPGs had been created in the last 5 years; yet, none were of particularly high quality, and most were not recommended by our reviewers. Specifically, 62% of the selected CPGs were deemed “low quality”: low-A (8%), low-B (39%), and low-C (15%). In essence, most of the CPGs scored less than 30% on the “rigor of development” domain. This domain evaluated how evidence for the CPG was assembled and synthesized, how recommendations were formulated, and how the CPG would be updated. Given the deficiencies within this metric, we can conclude poor quality of our selected CPGs. Similar to our findings, Chinese CPGs have been evaluated for poor quality, particularly presenting low scores on the “rigor of development” domain [<xref ref-type="bibr" rid="pone.0166367.ref074">74</xref>–<xref ref-type="bibr" rid="pone.0166367.ref077">77</xref>].</p>
<p>Another important finding was that CPGs published in/after 2009 (AGREE II publication) were rated more positively within 2 domains: “rigor of development” and “clarity and presentation.” One prior study evaluating CPGs published between 1980 and 2007 observed improvement over time in most domains [<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>]. However, domain scores were still moderate to low [<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>]. In contrast to these findings, “scope and purpose,” “stakeholder involvement,” and “applicability” domains did not improve post-2009 in the present study. These differences might be explained, in part, by sample size issues, country of origin, and publication year. While we only evaluated 26 Brazilian CPGs, the aforementioned study assessed 42 CPGs across different continents. Additionally, we believe that international CPGs obtain greater scores because the AGREE instrument has been used worldwide since 2003 [<xref ref-type="bibr" rid="pone.0166367.ref020">20</xref>]. The first AGREE version was not validated in Brazil, and AGREE II was not available until 2009. It is interesting to note that only Ministry of Health guidelines were recommended by our reviewers. This result may be explained by the fact that the Ministry of Health guidelines presented better scores in the “rigor of development” domain, with a minimum of 41%. In addition, these guidelines reported AGREE use for developing CPGs, which may be associated with higher quality when compared to others.</p>
<p>Independent from publication year, “scope and purpose” and “clarity and presentation” were more highly rated; however, there is still room for improvement within these domains owing to the presence of scores lower than 30% and between 30 and 60%. As previously reported [<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0166367.ref017">17</xref>], these domains can be ameliorated by describing the target population and health questions, providing clear summaries, and standardizing the CPG presentation form.</p>
<p>“Stakeholder involvement” and “applicability” were the lowest scoring domains, accruing scores &lt; 30%. Other studies [<xref ref-type="bibr" rid="pone.0166367.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0166367.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0166367.ref075">75</xref>] have also reported poor quality among these domains. We observed that the “stakeholder involvement” domain did not include consideration of patients’ perspectives, and developer groups were not multidisciplinary. With respect to the “applicability’ domain,” most CPGs did not evaluate resource implications and organizational barriers when applying recommendations, which has also been mentioned previously [<xref ref-type="bibr" rid="pone.0166367.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0166367.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0166367.ref075">75</xref>].</p>
<p>Several barriers affect physician adherence to CPG recommendations [<xref ref-type="bibr" rid="pone.0166367.ref078">78</xref>]. CPG developers should explore alternative tools for promoting adherence among healthcare providers. Tools, such as implementation instructions, flowcharts, digital books, and an outline of key recommendations, might be useful for promoting and disseminating CPGs [<xref ref-type="bibr" rid="pone.0166367.ref079">79</xref>]. This should improve “applicability” scores. Additionally, actions toward intensifying healthcare professionals’ participation in CPG development may also improve recommendation adherence [<xref ref-type="bibr" rid="pone.0166367.ref080">80</xref>,<xref ref-type="bibr" rid="pone.0166367.ref081">81</xref>], along with important domain scores. In Brazil, most CPG developers did not create multidisciplinary teams. For instance, specific medical societies only included specialty physicians, while the Brazilian Medical Association included some physicians from different expertise areas. Only the Ministry of Health included a multidisciplinary team and conducted public consultations. Furthermore, insufficient methods for procuring stakeholder views were reported. For instance, only the Ministry of Health’s guidelines conducted public consultations during the final step of guideline development. Few CPGs have conducted a literature search on stakeholder views. More effective CPG creation would likely include patients and patient representatives within the development group [<xref ref-type="bibr" rid="pone.0166367.ref082">82</xref>]. In accordance with our findings, a prior study analyzed 100 endocrine CPGs from North America and demonstrated that only 3 considered patient perspectives and included patients during CPG development [<xref ref-type="bibr" rid="pone.0166367.ref009">9</xref>].</p>
<p>It is interesting to note that all 26 CPGs reviewed presently were undermined by poor rigor of development, even when only analyzing guidelines published in/after 2009. Possible explanations for this result include: 1) no study performed a systematic review or adapted a high-quality CPG; 2) few detailed a specific search strategy and selection criteria; 3) few described the evidence considered and recommendations based on that evidence; and 4) a GRADE system was not used for most of the CPG recommendations. These problems directly affected the “rigor of development” score and overall CPG quality and reliability. Previous reports have noted that most CPGs do not perform a systematic literature search [<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0166367.ref083">83</xref>], as this can be very time-consuming. The AGREE II does not require a systematic review for a full score domain; however, to improve upon specific domain scores (namely “rigor of development,”), CPGs must explicitly describe their selection criteria and the type of evidence considered [<xref ref-type="bibr" rid="pone.0166367.ref042">42</xref>]. Low “rigor of development” scores might also be related to the various CPG versions that have been published (digital versions as eBooks, full vs. summary versions, etc.) [<xref ref-type="bibr" rid="pone.0166367.ref018">18</xref>]. For instance, the Ministry of Health provides partial methods sections and mentions specific CPG books. Medical societies often publish CPGs in scientific journals and digital books comprising flowcharts and recommendation summaries; however, most do not present a methods section. The Brazilian Medical Association provides digital books, including a general methods section for all CPGs published. Yet, no information regarding criteria selection and the formulation of recommendations is provided.</p>
<p>The “editorial independence” median score was 35.5% (interquartile range, 21–42%). Although most CPGs disclose authors’ competing interests, they did not address how identified conflicts would be managed. Moreover, none clearly disclosed funding sources. Thus, these results need to be interpreted with caution. AGREE II scores rely on CPG text; therefore, we believe that competing interests were properly assessed. A more careful description was lacking. Furthermore, low scores within this domain have been reported elsewhere [<xref ref-type="bibr" rid="pone.0166367.ref084">84</xref>]. Scores range from 16% among Chinese CPGs for hypertension to 30% for a separate analysis of 626 CPGs, and 41% for European CPGs specific to chronic diseases [<xref ref-type="bibr" rid="pone.0166367.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0166367.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0166367.ref075">75</xref>]. Moreover, a review of 250 CPGs observed the absence of author disclosures (40%), unavailable author disclosures within the public domain (42%), and at least 60% provided at least one author with a conflict [<xref ref-type="bibr" rid="pone.0166367.ref084">84</xref>].</p>
<p>In order to improve CPG quality, we suggest focusing on the following: 1) assembling a multidisciplinary development group; 2) take into account patients’ preferences; 3) describe literature search details, selection criteria, and the formulation of recommendations; and 4) explicitly declare any competing or financial interests among the authors. Finally, we believe high-quality CPGs will likely require a partnership between health institutions and universities with CPG development expertise. Previous work in Saudi Arabia has suggested that collaborative work between the Ministry of Health and McMaster University enabled the production of 10 CPGs, with 80 recommendations, within 4 months [<xref ref-type="bibr" rid="pone.0166367.ref085">85</xref>]. Thus, knowing that the Brazilian health system is a reference in Latin America, the Caribbean, and Portuguese-speaking African countries, the study of Brazilian CPGs is essential for healthcare professionals in many other countries. Health institutions should identify universities with CPG expertise and work collaboratively toward promoting high-quality CPG development and adaptation.</p>
<sec id="sec013">
<title>Limitations and strengths</title>
<p>To date, this is the first study to assess Brazilian CPGs’ quality for the most prevalent NCDs, as well as conduct a comprehensive search for identifying Brazilian guidelines. Prior Brazilian research evaluated only 8 Ministry of Health guidelines, and most were for managing rare diseases [<xref ref-type="bibr" rid="pone.0166367.ref018">18</xref>]. Nevertheless, the present study is limited by a subjective analysis of the AGREE II instrument. However, raters received exhaustive training on the instrument, which should ameliorate assessment concerns [<xref ref-type="bibr" rid="pone.0166367.ref021">21</xref>].</p>
</sec>
</sec>
<sec id="sec014" sec-type="conclusions">
<title>Conclusions</title>
<p>The present study evaluated Brazilian CPGs for treating the most prevalent NCDs. Our results revealed an urgent need to improve CPG development in Brazil. Healthcare professionals should be concerned with current CPG quality given that most were classified as low-B, suggesting poor “rigor of development” and less than stellar scores across additional domains. Overall, it is recommended that health institutions work in partnership with universities and adopt the AGREE II for improving CPGs’ quality.</p>
</sec>
<sec id="sec015">
<title>Supporting Information</title>
<supplementary-material id="pone.0166367.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.s001" xlink:type="simple">
<label>S1 Appendix</label>
<caption>
<title>Reviewers training in AGREE II instrument.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0166367.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.s002" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Overall quality classification for each CPG.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0166367.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.s003" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Systematic search strategies.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0166367.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.s004" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Excluded CPG information.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0166367.s005" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0166367.s005" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>PRISMA Checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We are grateful to Professor Airton Stein, Ana Marusic, and Bruno Caramelli for their review of this manuscript and helpful suggestions. We also thank Professor André Rolim Baby and Carlota de Oliveira Rangel Yagui for helpful advice on manuscript presentation.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0166367.ref001"><label>1</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization (WHO)</collab>. <source>Global Status Report On Noncommunicable Diseases 2014</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2014</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/chp/en/" xlink:type="simple">http://www.who.int/chp/en/</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref002"><label>2</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Pan American Health Organization</collab>. <source>Health in the Americas—Regional Outlook and Country Profiles</source>. <edition>2012th ed.</edition> <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>PAHO</publisher-name>; <year>2012</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/healthintheamericas/" xlink:type="simple">http://www.paho.org/healthintheamericas/</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref003"><label>3</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization (WHO)</collab>. <chapter-title>Noncommunicable diseases</chapter-title>. In: <publisher-name>WHO Mediacentre—Fact sheets</publisher-name>. <year>2015</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs355/en/" xlink:type="simple">http://www.who.int/mediacentre/factsheets/fs355/en/</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woolf</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Grol</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hutchinson</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Eccles</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Grimshaw</surname> <given-names>J</given-names></name>. <article-title>Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines</article-title>. <source>BMJ</source>. <year>1999</year>;<volume>318</volume>: <fpage>527</fpage>–<lpage>30</lpage>. <object-id pub-id-type="pmid">10024268</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haines</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>R</given-names></name>. <article-title>Implementing findings of research</article-title>. <source>BMJ</source>. <year>1994</year>;<volume>308</volume>: <fpage>1488</fpage>–<lpage>1492</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.308.6942.1488" xlink:type="simple">10.1136/bmj.308.6942.1488</ext-link></comment> <object-id pub-id-type="pmid">8019284</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wagner</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Austin</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Korff</surname> <given-names>V</given-names></name>. <article-title>Organizing care for patients with chronic illness</article-title>. <source>Milbank Q</source>. <year>1996</year>;<volume>74</volume>: <fpage>511</fpage>–<lpage>44</lpage>. <object-id pub-id-type="pmid">8941260</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wagner</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Austin</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Von Korff</surname> <given-names>M</given-names></name><article-title>. Improving outcomes in chronic illness</article-title>. <source>Manag Care Q</source>. <year>1996</year>;<volume>4</volume>: <fpage>12</fpage>–<lpage>25</lpage>.</mixed-citation></ref>
<ref id="pone.0166367.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bodenheimer</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Wagner</surname> <given-names>EH</given-names></name>. <article-title>Improving Primary Care for Patients With Chronic Illness</article-title>. <source>JAMA</source>. <year>2002</year>;<volume>288</volume>: <fpage>1775</fpage>–<lpage>1779</lpage>. <object-id pub-id-type="pmid">12365965</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bancos</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Prokop</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Montori</surname> <given-names>VM</given-names></name>, <name name-style="western"><surname>Murad</surname> <given-names>MH</given-names></name>. <article-title>Endocrine clinical practice guidelines in North America. A systematic assessment of quality</article-title>. <source>J Clin Epidemiol</source>. Elsevier Inc; <year>2012</year>;<volume>65</volume>: <fpage>520</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jclinepi.2011.07.014" xlink:type="simple">10.1016/j.jclinepi.2011.07.014</ext-link></comment> <object-id pub-id-type="pmid">22280992</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alonso-Coello</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Irfan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Solà</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Gich</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Delgado-Noguera</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rigau</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies</article-title>. <source>Qual Saf Heal Care</source>. <year>2010</year>;<volume>19</volume>: <fpage>e58</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/qshc.2010.042077" xlink:type="simple">10.1136/qshc.2010.042077</ext-link></comment> <object-id pub-id-type="pmid">21127089</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al-Ansary</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Tricco</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Adi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Bawazeer</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Perrier</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Al-Ghonaim</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A Systematic Review of Recent Clinical Practice Guidelines on the Diagnosis, Assessment and Management of Hypertension</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0053744" xlink:type="simple">10.1371/journal.pone.0053744</ext-link></comment> <object-id pub-id-type="pmid">23349738</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shaneyfelt</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Mayo-Smith</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Rothwangl</surname> <given-names>J</given-names></name>. <article-title>Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature</article-title>. <source>JAMA</source>. <year>1999</year>;<volume>281</volume>: <fpage>1900</fpage>–<lpage>5</lpage>. <object-id pub-id-type="pmid">10349893</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grilli</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Magrini</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Penna</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mura</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>. <article-title>Practice guidelines developed by specialty societies: the need for a critical appraisal</article-title>. <source>Lancet (London, England)</source>. <year>2000</year>;<volume>355</volume>: <fpage>103</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(99)02171-6" xlink:type="simple">10.1016/S0140-6736(99)02171-6</ext-link></comment></mixed-citation></ref>
<ref id="pone.0166367.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kryworuchko</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stacey</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Bai</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>ID</given-names></name>. <article-title>Twelve years of clinical practice guideline development, dissemination and evaluation in Canada (1994 to 2005)</article-title>. <source>Implement Sci</source>. <year>2009</year>;<volume>4</volume>: <fpage>49</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1748-5908-4-49" xlink:type="simple">10.1186/1748-5908-4-49</ext-link></comment> <object-id pub-id-type="pmid">19656384</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kung</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Mackowiak</surname> <given-names>PA</given-names></name>. <article-title>Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress</article-title>. <source>Arch Intern Med</source>. <year>2012</year>;<volume>172</volume>: <fpage>1628</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/2013.jamainternmed.56" xlink:type="simple">10.1001/2013.jamainternmed.56</ext-link></comment> <object-id pub-id-type="pmid">23089902</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>CAM</given-names></name>, <name name-style="western"><surname>Toupin-April</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Jutai</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Duffy</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Rahman</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Cavallo</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>A systematic critical appraisal of clinical practice guidelines in juvenile idiopathic arthritis using the appraisal of guidelines for research and evaluation II (AGREE II) instrument</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>: <fpage>1</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0137180" xlink:type="simple">10.1371/journal.pone.0137180</ext-link></comment> <object-id pub-id-type="pmid">26356098</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knai</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Brusamento</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Legido-Quigley</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Saliba</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Panteli</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Turk</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe</article-title>. <source>Health Policy (New York)</source>. <year>2012</year>;<volume>107</volume>: <fpage>157</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.healthpol.2012.06.004" xlink:type="simple">10.1016/j.healthpol.2012.06.004</ext-link></comment> <object-id pub-id-type="pmid">22795610</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ronsoni</surname> <given-names>RDM</given-names></name>, <name name-style="western"><surname>Pereira</surname> <given-names>CC de A</given-names></name>, <name name-style="western"><surname>Stein</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Osanai</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Machado</surname> <given-names>CJ</given-names></name>. [<article-title>Evaluation of eight Clinical Protocols and Therapeutic Guidelines under the Brazilian Ministry of Health using the AGREE II instrument: a pilot study</article-title>]. <source>Cad Saúde Pública</source>. <year>2015</year>;<volume>31</volume>: <fpage>1157</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/0102-311X00118814" xlink:type="simple">10.1590/0102-311X00118814</ext-link></comment> <object-id pub-id-type="pmid">26200364</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vlayen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Aertgeerts</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hannes</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sermeus</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ramakers</surname> <given-names>D</given-names></name>. <article-title>A systematic review of appraisal tools for clinical practice guidelines: Multiple similarities and one common deficit</article-title>. <source>Int J Qual Heal Care</source>. <year>2005</year>;<volume>17</volume>: <fpage>235</fpage>–<lpage>242</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/intqhc/mzi027" xlink:type="simple">10.1093/intqhc/mzi027</ext-link></comment> <object-id pub-id-type="pmid">15743883</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siering</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Eikermann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hausner</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hoffmann-E??er</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Neugebauer</surname> <given-names>EA</given-names></name>. <article-title>Appraisal tools for clinical practice guidelines: A systematic review</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0082915" xlink:type="simple">10.1371/journal.pone.0082915</ext-link></comment> <object-id pub-id-type="pmid">24349397</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brouwers</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Kho</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Browman</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Burgers</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Cluzeau</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Feder</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>AGREE II: Advancing guideline development, reporting and evaluation in health care</article-title>. <source>CMAJ</source>. <year>2010</year>;<volume>182</volume>: <fpage>E839</fpage>–<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1503/cmaj.090449" xlink:type="simple">10.1503/cmaj.090449</ext-link></comment> <object-id pub-id-type="pmid">20603348</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Su</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>X</given-names></name>. <article-title>Evaluation of the quality of guidelines for myasthenia gravis with the AGREE II instrument</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0111796" xlink:type="simple">10.1371/journal.pone.0111796</ext-link></comment> <object-id pub-id-type="pmid">25402504</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Min</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>B</given-names></name>. <article-title>Diagnosis of pheochromocytoma: A clinical practice guideline appraisal using AGREE II instrument</article-title>. <source>J Eval Clin Pract</source>. <year>2013</year>;<volume>19</volume>: <fpage>626</fpage>–<lpage>632</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2753.2012.01873.x" xlink:type="simple">10.1111/j.1365-2753.2012.01873.x</ext-link></comment> <object-id pub-id-type="pmid">22809219</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Serón</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lanas</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ríos</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bonfill</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Alonso-Coello</surname> <given-names>P</given-names></name>. <article-title>Evaluation of the Quality of Clinical Guidelines for Cardiac Rehabilitation</article-title>. <source>J Cardiopulm Rehabil Prev</source>. <year>2015</year>;<volume>35</volume>: <fpage>1</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/HCR.0000000000000075" xlink:type="simple">10.1097/HCR.0000000000000075</ext-link></comment> <object-id pub-id-type="pmid">25068394</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tudor</surname> <given-names>KI</given-names></name>, <name name-style="western"><surname>Kozina</surname> <given-names>PN</given-names></name>, <name name-style="western"><surname>Marusic</surname> <given-names>A</given-names></name>. <article-title>Methodological Rigour and Transparency of Clinical Practice Guidelines Developed by Neurology Professional Societies in Croatia</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0069877" xlink:type="simple">10.1371/journal.pone.0069877</ext-link></comment> <object-id pub-id-type="pmid">23894555</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marengoni</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Angleman</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Melis</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Mangialasche</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Karp</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Garmen</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Aging with multimorbidity: A systematic review of the literature</article-title>. <source>Ageing Res Rev</source>. <year>2011</year>;<volume>10</volume>: <fpage>430</fpage>–<lpage>39</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.arr.2011.03.003" xlink:type="simple">10.1016/j.arr.2011.03.003</ext-link></comment> <object-id pub-id-type="pmid">21402176</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vitry</surname> <given-names>AI</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>. <article-title>Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions</article-title>. <source>Med J Aust</source>. <year>2008</year>;<volume>189</volume>: <fpage>360</fpage>–<lpage>5</lpage>. <object-id pub-id-type="pmid">18837677</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boyd</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>McNabrey</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Brandt</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Correa-de-Araujo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Daniel</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Epplin</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity</article-title>. <source>J Am Geriatr Soc</source>. <year>2012</year>;<volume>60</volume>: <fpage>E1</fpage>–<lpage>E25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1532-5415.2012.04188.x" xlink:type="simple">10.1111/j.1532-5415.2012.04188.x</ext-link></comment> <object-id pub-id-type="pmid">22994865</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Menotti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mulder</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Nissinen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Giampaoli</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Feskens</surname> <given-names>EJM</given-names></name>, <name name-style="western"><surname>Kromhout</surname> <given-names>D</given-names></name>. <article-title>Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortalitym: The FINE study (Finland, Italy, Netherlands, elderly)</article-title>. <source>J Clin Epidemiol</source>. <year>2001</year>;<volume>54</volume>: <fpage>680</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0895-4356(00)00368-1" xlink:type="simple">10.1016/S0895-4356(00)00368-1</ext-link></comment> <object-id pub-id-type="pmid">11438408</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Soubhi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Fortin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hudon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>O’Dowd</surname> <given-names>T</given-names></name>. <article-title>Managing patients with multimorbidity: systematic review of interventions in primary care and community settings</article-title>. <source>BMJ</source>. <year>2012</year>;<volume>345</volume>: <fpage>e5205</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.e5205" xlink:type="simple">10.1136/bmj.e5205</ext-link></comment> <object-id pub-id-type="pmid">22945950</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bower</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Macdonald</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Harkness</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Gask</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Kendrick</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Valderas</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Multimorbidity, service organization and clinical decision making in primary care: a qualitative study</article-title>. <source>Fam Pract</source>. <year>2011</year>;<volume>28</volume>: <fpage>579</fpage>–<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/fampra/cmr018" xlink:type="simple">10.1093/fampra/cmr018</ext-link></comment> <object-id pub-id-type="pmid">21613378</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lefèvre</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>D’Ivernois</surname> <given-names>J-F</given-names></name>, <name name-style="western"><surname>De Andrade</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Crozet</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lombrail</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Gagnayre</surname> <given-names>R</given-names></name>. <article-title>What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization</article-title>. <source>Rev Epidemiol Sante Publique</source>. <year>2014</year>;<volume>62</volume>: <fpage>305</fpage>–<lpage>314</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.respe.2014.09.002" xlink:type="simple">10.1016/j.respe.2014.09.002</ext-link></comment> <object-id pub-id-type="pmid">25444838</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lorgunpai</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Grammas</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>DSH</given-names></name>, <name name-style="western"><surname>McAvay</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Charpentier</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Tinetti</surname> <given-names>ME</given-names></name>. <article-title>Potential therapeutic competition in community-living older adults in the U.S.: Use of medications that may adversely affect a coexisting condition</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>: <fpage>e89447</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0089447" xlink:type="simple">10.1371/journal.pone.0089447</ext-link></comment> <object-id pub-id-type="pmid">24586786</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmidt</surname> <given-names>MI</given-names></name>, <name name-style="western"><surname>Duncan</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Mill</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Lotufo</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Chor</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Barreto</surname> <given-names>SM</given-names></name>, <etal>et al</etal>. <article-title>Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil)</article-title>. <source>Int J Epidemiol</source>. <year>2014</year>; <fpage>1</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ije/dyu027" xlink:type="simple">10.1093/ije/dyu027</ext-link></comment> <object-id pub-id-type="pmid">24585730</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref035"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">U.S. National Library of Medicine. MEDLINE/PubMed. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref036"><label>36</label><mixed-citation publication-type="book" xlink:type="simple"><collab>BIREME—PAHO—WHO</collab>. <source>Evidence Portal</source>. In: <publisher-name>Latin-American and Caribbean Center on Health Sciences Information</publisher-name>. Available: <ext-link ext-link-type="uri" xlink:href="http://evidences.bvsalud.org/php/index.php" xlink:type="simple">http://evidences.bvsalud.org/php/index.php</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref037"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Cochrane Collaboration. Cochrane Library. Available: <ext-link ext-link-type="uri" xlink:href="http://www.cochranelibrary.com/" xlink:type="simple">http://www.cochranelibrary.com/</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref038"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Agency for Healthcare Research and Quality (AHRQ). National Guideline Clearinghouse. Available: <ext-link ext-link-type="uri" xlink:href="https://www.guideline.gov/" xlink:type="simple">https://www.guideline.gov/</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref039"><label>39</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Institute of Medicine (IOM)</collab>. <source>Clinical Practice Guidelines We Can Trust</source>. <name name-style="western"><surname>Graham</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Mancher</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wolman</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Greenfield</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Steinberg</surname> <given-names>E</given-names></name>, editors. <publisher-loc>Washington, D.C.</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>; <year>2011</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.nap.edu" xlink:type="simple">www.nap.edu</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khan</surname> <given-names>GSC</given-names></name>, <name name-style="western"><surname>Stein</surname> <given-names>AT</given-names></name>. [<article-title>Cross-cultural adaptation of the instrument Appraisal of Guidelines For Research &amp; Evaluation II (AGREE II) for assessment of clinical guidelines</article-title>]. <source>Cad Saúde Pública</source>. <year>2014</year>;<volume>30</volume>: <fpage>1111</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/0102-311X00174912" xlink:type="simple">10.1590/0102-311X00174912</ext-link></comment> <object-id pub-id-type="pmid">24936826</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Legido-Quigley</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Panteli</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Brusamento</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Knai</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Saliba</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Turk</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Clinical guidelines in the European Union: Mapping the regulatory basis, development, quality control, implementation and evaluation across member states</article-title>. <source>Health Policy (New York)</source>. <year>2012</year>;<volume>107</volume>: <fpage>146</fpage>–<lpage>156</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.healthpol.2012.08.004" xlink:type="simple">10.1016/j.healthpol.2012.08.004</ext-link></comment> <object-id pub-id-type="pmid">22939646</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref042"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">AGREE Next Steps Consortium (2009). The AGREE II Instrument [Electronic version]. Available: <ext-link ext-link-type="uri" xlink:href="http://www.agreetrust.org" xlink:type="simple">http://www.agreetrust.org</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref043"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Lowry R. VassarStats: Website for Statistical Computation. Available: <ext-link ext-link-type="uri" xlink:href="http://vassarstats.net/kappa.html" xlink:type="simple">http://vassarstats.net/kappa.html</ext-link>.</mixed-citation></ref>
<ref id="pone.0166367.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>GG</given-names></name>. <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics</source>. <year>1977</year>;<volume>3</volume>: <fpage>159</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2307/2529310" xlink:type="simple">10.2307/2529310</ext-link></comment></mixed-citation></ref>
<ref id="pone.0166367.ref045"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">McMaster University. McMaster AGREE II score calculator Excel spreadsheet. Available: <ext-link ext-link-type="uri" xlink:href="http://fhswedge.csu.mcmaster.ca/cepftp/qasite/CriticalAppraisal.html" xlink:type="simple">http://fhswedge.csu.mcmaster.ca/cepftp/qasite/CriticalAppraisal.html</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poitras</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Avouac</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rossignol</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Avouac</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Cedraschi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Nordin</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria</article-title>. <source>Arthritis Res Ther</source>. <year>2007</year>;<volume>9</volume>: <fpage>R126</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/ar2339" xlink:type="simple">10.1186/ar2339</ext-link></comment> <object-id pub-id-type="pmid">18062805</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chui</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Onishko</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Coulthard</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>McKinnon</surname> <given-names>R</given-names></name>. <article-title>Incidence of Vancomycin-Induced Red Man Syndrome in a Women’s and Children’s Hospital</article-title>. <source>J Pharm Pract Res</source>. <year>2007</year>;<volume>37</volume>: <fpage>124</fpage>–<lpage>126</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/j.2055-2335.2007.tb00033.x" xlink:type="simple">10.1002/j.2055-2335.2007.tb00033.x</ext-link></comment></mixed-citation></ref>
<ref id="pone.0166367.ref048"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Brazil. Ministry of Health. [Clinical Protocol and Therapeutic Guidelines—Alzheimer’s disease]. 2013. Available: <ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/images/pdf/2014/abril/02/pcdt-doenca-de-alzheimer-livro-2013.pdf" xlink:type="simple">http://portalsaude.saude.gov.br/images/pdf/2014/abril/02/pcdt-doenca-de-alzheimer-livro-2013.pdf</ext-link>. Accessed 31 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref049"><label>49</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Lopes</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Araújo</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chaves</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Imamura</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Okamoto</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Ramos</surname> <given-names>A</given-names></name>, <etal>et al</etal>. [<source>Alzheimer’s Disease: Prevention and Treatment</source>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2011</year> Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/ans/diretrizes/doenca_de_alzheimer-prevencao_e_tratamento.pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/ans/diretrizes/doenca_de_alzheimer-prevencao_e_tratamento.pdf</ext-link>. Accessed 30 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref050"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Brazil. Ministry of Health. [Clinical Protocol and Therapeutic Guidelines—Asthma]. 2013 Available: <ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/images/pdf/2014/julho/22/PT-SAS-N—1317-alterado-pela-603-de-21-de-julho-de-2014.pdf" xlink:type="simple">http://portalsaude.saude.gov.br/images/pdf/2014/julho/22/PT-SAS-N—1317-alterado-pela-603-de-21-de-julho-de-2014.pdf</ext-link>. Accessed 31 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>Brazilian Society of Pneumology and Tisiology</collab>. [<article-title>Brazilian Guidelines for the management of asthma—2012</article-title>]. <source>J Pneumol</source>. <year>2012</year>;<volume>38</volume>: <fpage>S1</fpage>–<lpage>46</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.sbpt.org.br/downloads/arquivos/COM_ASMA/SBPT_DIRETRIZES_MANEJO_ASMA_SBPT_2012.pdf" xlink:type="simple">http://www.sbpt.org.br/downloads/arquivos/COM_ASMA/SBPT_DIRETRIZES_MANEJO_ASMA_SBPT_2012.pdf</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zimerman</surname> <given-names>LI</given-names></name>, <name name-style="western"><surname>Fenelon</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Martinelli-Filho</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Grupi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Atié</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lorga-Filho</surname> <given-names>A</given-names></name>. [<article-title>Brazilian atrial fibrillation guidelines</article-title>]. <source>Arq Bras Cardiol</source>. <year>2009</year>;<volume>92</volume>: <fpage>1</fpage>–<lpage>39</lpage>.</mixed-citation></ref>
<ref id="pone.0166367.ref053"><label>53</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Cavalcanti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Errico</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Araujo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ribeiro</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Scaletsky</surname> <given-names>R</given-names></name>. [<chapter-title>Benign prostatic hyperplasia</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2006</year>.Available: <ext-link ext-link-type="uri" xlink:href="http://projetodiretrizes.org.br/5_volume/24-Hiperpla.pdf" xlink:type="simple">http://projetodiretrizes.org.br/5_volume/24-Hiperpla.pdf</ext-link> Accessed 30 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref054"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Brazil. Ministry of Health. [Clinical Protocol and Therapeutic Guidelines—Chronic obstructive pulmonary disease]. Available: <ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/images/pdf/2014/junho/13/Portaria-609-de-2013.pdf" xlink:type="simple">http://portalsaude.saude.gov.br/images/pdf/2014/junho/13/Portaria-609-de-2013.pdf</ext-link>. Accessed 31 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref055"><label>55</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Lundgren</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Maranhão</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Jardim</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Fernandes</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Mattos</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Teixeira</surname> <given-names>P</given-names></name>, <etal>et al</etal>. [<chapter-title>Chronic obstructive pulmonary disease: exacerbation</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2012</year> Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/diretrizes11/doenca_pulmonar_obstrutiva_cronica_exacerbacao.pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/diretrizes11/doenca_pulmonar_obstrutiva_cronica_exacerbacao.pdf</ext-link>. Accessed 30 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>Brazilian Society of Pneumology and Tisiology</collab>. [<article-title>II Brazilian Consensus on Chronic obstructive pulmonary disease—COPD—2004</article-title>]. <source>J Bras Pneumol</source>. <year>2004</year>;<volume>30</volume>: <fpage>S1</fpage>–<lpage>S42</lpage>. ISSN 1806-3713</mixed-citation></ref>
<ref id="pone.0166367.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bocchi</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Marcondes-Braga</surname> <given-names>FG</given-names></name>, <name name-style="western"><surname>Bacal</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ferraz</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Albuquerque</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Rodrigues</surname> <given-names>D</given-names></name>, <etal>et al</etal>. [<article-title>Updating of the Brazilian guideline for chronic heart failure—2012</article-title>]. <source>Arq Bras Cardiol</source>. <year>2012</year>;<volume>98</volume>: <fpage>1</fpage>–<lpage>33</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S0066-782X2012000700001" xlink:type="simple">http://dx.doi.org/10.1590/S0066-782X2012000700001</ext-link> <object-id pub-id-type="pmid">22392082</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cesar</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ferreira</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Armaganijan</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Gowdak</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Mansur</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bodanese</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Guideline for Stable Coronary Artery Disease</article-title>. <source>Arq Bras Cardiol</source>. <year>2014</year>;<volume>103</volume>: <fpage>1</fpage>–<lpage>59</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5935/abc.2014S004" xlink:type="simple">http://dx.doi.org/10.5935/abc.2014S004</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref059"><label>59</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Fleck</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chagas</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Guapo</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Brasil</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Giribela</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Toledo</surname> <given-names>S</given-names></name>, <etal>et al</etal>. [<chapter-title>Unipolar depression: treatment</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2011</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/ans/diretrizes/depressao_unipolar-Tratamento.pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/ans/diretrizes/depressao_unipolar-Tratamento.pdf</ext-link>. Accessed 30 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref060"><label>60</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Brazilian Society of Diabetes</collab>. [<source>Guidelines of the Brazilian Society of Diabetes 2014–2015</source>]. <publisher-loc>São Paulo</publisher-loc>: <publisher-name>AC Farmacêutica</publisher-name>; <year>2015</year>.</mixed-citation></ref>
<ref id="pone.0166367.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Soeiro A de</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mansur A de</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Schaan</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Caramelli</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Rochitte</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Serrano</surname> <given-names>CV</given-names> <suffix>Jr.</suffix></name>, <etal>et al</etal>. [<article-title>I Guideline on specific aspects of diabetes (type 2) related to cardiology</article-title>]. <source>Arq Bras Cardiol</source>. <year>2014</year>;<volume>102</volume>: <fpage>1</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5935/abc.2014S002" xlink:type="simple">10.5935/abc.2014S002</ext-link></comment> <object-id pub-id-type="pmid">27223869</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref062"><label>62</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Macedo</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Moura</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Soriano</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Ribas DF</surname> <given-names>AN</given-names></name>. [<source>Type 2 Diabetes Mellitus: Insulinization</source>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2011</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/diretrizes10/diabetes_mellitus_tipo_2_insulinizacao.pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/diretrizes10/diabetes_mellitus_tipo_2_insulinizacao.pdf</ext-link>. Accessed 30 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref063"><label>63</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Sgarbi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Villar</surname> <given-names>H</given-names></name>. [<chapter-title>Diabetes Mellitus: pharmacological treatment</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2004</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/4_volume/13-Diabetes.pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/4_volume/13-Diabetes.pdf</ext-link>. Accessed 30 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref064"><label>64</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Carvalhaes</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ferrari</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Magalhães</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nasy</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Paula e Silva</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hashimoto</surname> <given-names>C</given-names></name>, <etal>et al</etal>. [<chapter-title>Gastroesophageal reflux disease: pharmacological treatment</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2011</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/ans/diretrizes/doenca_do_refluxo_gastroesofagico-tratamento_farmacologico.pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/ans/diretrizes/doenca_do_refluxo_gastroesofagico-tratamento_farmacologico.pdf</ext-link>. Accessed 30 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref065"><label>65</label><mixed-citation publication-type="other" xlink:type="simple">Brazil. Ministry of Health. [Clinical Protocol and Therapeutic Guidelines—Dyslipidemia: prevention of cardiovascular and pancreatitis events]. 2013 Available: <ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/images/pdf/2014/abril/02/pcdt-dislipidemia-livro-2013.pdf" xlink:type="simple">http://portalsaude.saude.gov.br/images/pdf/2014/abril/02/pcdt-dislipidemia-livro-2013.pdf</ext-link>. Accessed 31 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xavier</surname> <given-names>HT</given-names></name>, <name name-style="western"><surname>Izar</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Faria Neto</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Assad</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Rocha</surname> <given-names>VZ</given-names></name>, <name name-style="western"><surname>Sposito</surname> <given-names>AC</given-names></name>, <etal>et al</etal>. [<article-title>V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis</article-title>]. <source>Arq Bras Cardiol</source>. <year>2013</year>;<volume>101</volume>: <fpage>1</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5935/abc.2013S010" xlink:type="simple">10.5935/abc.2013S010</ext-link></comment> <object-id pub-id-type="pmid">24217493</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref067"><label>67</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Martins</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Araújo</surname> <given-names>L</given-names></name>. [<chapter-title>Diabetes Mellitus: treatment of hypertension</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2004</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.amrigs.org.br/revista/47-02/Vacinas.pdf#page=2" xlink:type="simple">http://www.amrigs.org.br/revista/47-02/Vacinas.pdf#page=2</ext-link>. Accessed 1 January 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>Brazilian Society of Cardiology</collab>, <collab>Brazilian Society of Hypertension</collab>, <collab>Brazilian Society of Nephrology</collab>. [<article-title>VI Brazilian Guidelines on Hypertension</article-title>]. <source>Arq Bras Cardiol</source>. <year>2010</year>;<volume>95</volume>: <fpage>1</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S0066-782X2010001700001" xlink:type="simple">10.1590/S0066-782X2010001700001</ext-link></comment></mixed-citation></ref>
<ref id="pone.0166367.ref069"><label>69</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Coimbra</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Ferreira</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Coimbra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Andrada</surname> <given-names>N</given-names></name>. [<chapter-title>Use of nonsteroidal antiinflammatory drugs in chronic pain in patients with osteoarthritis (osteoarthrosis)</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2011</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/ans/diretrizes/uso_dos_anti-inflamatorios_nao_hormonais_na_dor_cronica_em_pacientes_com_osteoartrite_(osteoartrose).pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/ans/diretrizes/uso_dos_anti-inflamatorios_nao_hormonais_na_dor_cronica_em_pacientes_com_osteoartrite_(osteoartrose).pdf</ext-link></mixed-citation></ref>
<ref id="pone.0166367.ref070"><label>70</label><mixed-citation publication-type="other" xlink:type="simple">Brazil. Ministry of Health. [Clinical Protocol and Therapeutic Guidelines—Osteoporosis]. 2014. Available: <ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/images/pdf/2014/dezembro/15/Osteoporose.pdf" xlink:type="simple">http://portalsaude.saude.gov.br/images/pdf/2014/dezembro/15/Osteoporose.pdf</ext-link>. Accessed 31 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref071"><label>71</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Cunha</surname> <given-names>EP</given-names></name>; <name name-style="western"><surname>Steiner</surname> <given-names>ML</given-names></name>; <name name-style="western"><surname>Strufaldi</surname> <given-names>R</given-names></name>; <name name-style="western"><surname>Fernandes</surname> <given-names>C</given-names></name>; <name name-style="western"><surname>Laurindo</surname> <given-names>IMM</given-names></name>; <name name-style="western"><surname>Pereira</surname> <given-names>RMR</given-names></name>; <name name-style="western"><surname>Simões</surname> <given-names>R</given-names></name>. [<chapter-title>Osteoporosis: treatment</chapter-title>]. In: <publisher-name>Brazilian Medical Association</publisher-name>. <year>2011</year>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.projetodiretrizes.org.br/ans/diretrizes/osteoporose-tratamento.pdf" xlink:type="simple">http://www.projetodiretrizes.org.br/ans/diretrizes/osteoporose-tratamento.pdf</ext-link>. Accessed 3o October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref072"><label>72</label><mixed-citation publication-type="other" xlink:type="simple">Brazil. Ministry of Health. [Clinical Protocol and Therapeutic Guidelines—Rheumatoid arthritis]. 2015. Available: <ext-link ext-link-type="uri" xlink:href="http://portalsaude.saude.gov.br/images/pdf/2016/marco/08/pcdt-Artrite-Reumat—ide—Portaria-SAS-996-PCDT-AR-30-09-2015.pdf" xlink:type="simple">http://portalsaude.saude.gov.br/images/pdf/2016/marco/08/pcdt-Artrite-Reumat—ide—Portaria-SAS-996-PCDT-AR-30-09-2015.pdf</ext-link> Accessed 31 October 2015.</mixed-citation></ref>
<ref id="pone.0166367.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><string-name>LMH da</string-name>, <name name-style="western"><surname>Cruz</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Brenol</surname> <given-names>CV</given-names></name>, <name name-style="western"><surname>Pereira</surname> <given-names>IA</given-names></name>, <name name-style="western"><surname>Rezende-Fronza</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Bertolo</surname> <given-names>MB</given-names></name>, <etal>et al</etal>. <article-title>2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis</article-title>. <source>Rev Bras Reumatol</source>. <year>2012</year>;<volume>52</volume>: <fpage>152</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S0482-50042012000200002" xlink:type="simple">10.1590/S0482-50042012000200002</ext-link></comment> <object-id pub-id-type="pmid">22460407</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Leng</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kunnamo</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>The quality of clinical practice guidelines in China: a systematic assessment</article-title>. <source>J Eval Clin Pr</source>. <year>2013</year>;<volume>19</volume>: <fpage>961</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2753.2012.01893.x" xlink:type="simple">10.1111/j.1365-2753.2012.01893.x</ext-link></comment> <object-id pub-id-type="pmid">22845397</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Shen</surname> <given-names>G</given-names></name>. <article-title>Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality</article-title>. <source>BMJ Open</source>. <year>2015</year>;<volume>5</volume>: <fpage>e008099</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmjopen-2015-008099" xlink:type="simple">10.1136/bmjopen-2015-008099</ext-link></comment> <object-id pub-id-type="pmid">26179649</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Liao</surname> <given-names>L-Y</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>X-Q</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>W-Q</given-names></name>, <name name-style="western"><surname>Guan</surname> <given-names>W-J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Quality Assessment of Clinical Practice Guidelines for Respiratory Diseases in China: A Systematic Appraisal</article-title>. <source>Chest</source>. The American College of Chest Physicians; <year>2015</year>;<volume>148</volume>: <fpage>759</fpage>–<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1378/chest.14-3201" xlink:type="simple">10.1378/chest.14-3201</ext-link></comment> <object-id pub-id-type="pmid">25950752</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>Y-L</given-names></name>, <name name-style="western"><surname>Yao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>X-J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Z-H</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>F-X</given-names></name>, <etal>et al</etal>. <article-title>Quality assessment of clinical guidelines in China: 1993–2010</article-title>. <source>Chin Med J (Engl)</source>. <year>2012</year>;<volume>125</volume>: <fpage>3660</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2012.20.011" xlink:type="simple">10.3760/cma.j.issn.0366-6999.2012.20.011</ext-link></comment></mixed-citation></ref>
<ref id="pone.0166367.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cabana</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Rand</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Powe</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Abboud</surname> <given-names>P-AC</given-names></name>, <etal>et al</etal>. <article-title>Why Don’t Physicians Follow Clinical Practice Guidelines? A Framework for Improvement</article-title>. <source>JAMA</source>. <year>1999</year>;<volume>282</volume>: <fpage>1458</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.282.15.1458" xlink:type="simple">10.1001/jama.282.15.1458</ext-link></comment> <object-id pub-id-type="pmid">10535437</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murthy</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Shepperd</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Clarke</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Garner</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Lavis</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Perrier</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2012</year>;<volume>9</volume>: <fpage>CD009401</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/14651858.CD009401.pub2" xlink:type="simple">10.1002/14651858.CD009401.pub2</ext-link></comment> <object-id pub-id-type="pmid">22972142</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kunz</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Fretheim</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cluzeau</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wilt</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Qaseem</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lelgemann</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Guideline group composition and group processes: article 3 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report</article-title>. <source>Proc Am Thorac Soc</source>. <year>2012</year>;<volume>9</volume>: <fpage>229</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1513/pats.201208-056ST" xlink:type="simple">10.1513/pats.201208-056ST</ext-link></comment> <object-id pub-id-type="pmid">23256164</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fretheim</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Schünemann</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Oxman</surname> <given-names>AD</given-names></name>. <article-title>Improving the use of research evidence in guideline development: 3. Group composition and consultation process.</article-title> <source>Health Res Policy Syst</source>. <year>2006</year>;<volume>4</volume>: <fpage>15</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1478-4505-4-15" xlink:type="simple">10.1186/1478-4505-4-15</ext-link></comment> <object-id pub-id-type="pmid">17134482</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hudon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fortin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Haggerty</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Loignon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lambert</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Poitras</surname> <given-names>ME</given-names></name>. <article-title>Patient-centered care in chronic disease management: A thematic analysis of the literature in family medicine</article-title>. <source>Patient Educ Couns</source>. <year>2012</year>;<volume>88</volume>: <fpage>170</fpage>–<lpage>176</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pec.2012.01.009" xlink:type="simple">10.1016/j.pec.2012.01.009</ext-link></comment> <object-id pub-id-type="pmid">22360841</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Piano</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Schalkwijk</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Burgers</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Verhagen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kress</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hekster</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Guidelines for neuropathic pain management in patients with cancer: a European survey and comparison</article-title>. <source>Pain Pract</source>. <year>2013</year>;<volume>13</volume>: <fpage>349</fpage>–<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1533-2500.2012.00602.x" xlink:type="simple">10.1111/j.1533-2500.2012.00602.x</ext-link></comment> <object-id pub-id-type="pmid">23067004</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Norris</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Holmer</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Ogden</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Selph</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>R</given-names></name>. <article-title>Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse</article-title>. <source>PLoS One</source>. Public Library of Science; <year>2012</year>;<volume>7</volume>: <fpage>e47343</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0047343" xlink:type="simple">10.1371/journal.pone.0047343</ext-link></comment> <object-id pub-id-type="pmid">23144816</object-id></mixed-citation></ref>
<ref id="pone.0166367.ref085"><label>85</label><mixed-citation publication-type="other" xlink:type="simple">Rayess Z Al, Wiercioch W. A new approach to CPG adaptation in Saudi Arabia: Adaptation of practice guidelines to a country-specific context using the GRADE/DECIDE evidence to decision framework. GIN Conference. Melbourne; 2014. Available: <ext-link ext-link-type="uri" xlink:href="http://www.decide-collaboration.eu/sites/www.decide-collaboration.eu/files/uploads/140822_CPG_FridayRm1041100ZulfaAlRayess1.pdf" xlink:type="simple">http://www.decide-collaboration.eu/sites/www.decide-collaboration.eu/files/uploads/140822_CPG_FridayRm1041100ZulfaAlRayess1.pdf</ext-link></mixed-citation></ref>
</ref-list>
</back>
</article>